Group 1 - The Fourth China (Macau) International High-Quality Consumption Expo and Hengqin World Bay Area Forum will be held from September 3 to 7, featuring a strong lineup of central state-owned enterprises (SOEs) [2][3] - The event will include a special exhibition area for intangible cultural heritage, showcasing original works from Jiangxi, Yunnan, Hunan, and Suzhou, along with exquisite Chinese porcelain and various gourmet foods [2] - The expo aims to promote high-level opening up and industrial upgrading, serving as a platform for expanding business channels and deepening international cooperation [3] Group 2 - Central SOEs such as China Telecom, COFCO, and China National Pharmaceutical Group will present high-quality products, demonstrating the strength and influence of state-owned enterprises in innovation and cultural output [3][4] - The event will also feature a cultural tourism theme forum, focusing on the integration of cultural and tourism sectors, discussing various industries such as performing arts, e-sports, and digital art [4] - The participation of diverse enterprises highlights the potential for international collaboration and the showcasing of Chinese manufacturing capabilities [3]

证券代码：688799 证券简称：华纳药厂 公告编号：2025-052 湖南华纳大药厂股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 投资基金名称及投资方向，与上市公司主营业务相关性：苏州融信健康产 业创业投资中心（有限合伙）（暂定名，以企业登记机关最终核准登记的名称为 准，以下简称"融信健康"或"合伙企业"），该基金投资于具有创新医药产品、 新剂型、复杂制剂等高技术门槛和较大发展潜力的成长期、非上市企业股权投 资，与公司主营业务具备相关性。 投资金额、在投资基金中的占比及身份：公司拟作为有限合伙人以自有资 金认缴出资不超过人民币 1,000 万元。 相关风险提示： 最终签署的正式协议为准，本事项实施过程尚存在一定的不确定性；基金设立 过程中存在可能因合伙人未能缴足认缴资金等客观原因，导致基金未能成功募 足资金的风险，实际募集及各方缴付出资情况可能存在不确定性； 投资基金业协会备案，本事项实施过程尚存在一定的不确定性； 限合伙人承担的风险敞口以投资额为限，本次投资无保本及最低收益的承诺。 公司 ...